| Serial Number | 88686161 |
| Word Mark | IMPACT |
| Filing Date | Saturday, November 9, 2019 |
| Status | 711 - CANCELLED - SECTION 7 |
| Status Date | Wednesday, November 8, 2023 |
| Registration Number | 6183342 |
| Registration Date | Tuesday, October 27, 2020 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 11, 2020 |
| Goods and Services | Scientific analysis services, namely, neoepitope selection; neoepitope research, development and production of pharmaceuticals comprising personalized adoptive cell therapies; scientific analysis of neoepitopes; research, development and production of pharmaceuticals comprising the selection of and genetic encoding of neoepitopes; research, development and production of pharmaceuticals comprising adoptive cell therapies design of personalized adoptive cell therapies; medical analysis services, namely, detection of truncal cancer mutations in patient tumor cells; developing personal scientific treatment strategies for patients with diagnosed cancer; pharmaceutical product development and evaluation services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials involving neoepitopes; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; scientific collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; Conducting early evaluations in the field of new pharmaceuticals; Providing scientific research advice regarding selection of a neoepitope for the design of a cell therapy and/or immunotherapy product |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 1 - Sec. 7(d) - Entire Registration |
| Class Status Date | Wednesday, November 8, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, May 1, 2017 |
| First Use In Commerce Date | Monday, May 1, 2017 |
| Party Name | PACT Pharma, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | PACT Pharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | PACT Pharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Event Date | Event Description |
| Thursday, November 9, 2023 | NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED |
| Wednesday, November 8, 2023 | CANCELLED SECTION 7-TOTAL |
| Friday, June 16, 2023 | REQUEST FOR SECT 7 TOTAL SURRENDER FILED |
| Tuesday, November 7, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, November 7, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, June 16, 2023 | TEAS SECTION 7 SURRENDER RECEIVED |
| Tuesday, October 27, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 11, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 11, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 22, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, July 9, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 8, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 7, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 7, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 20, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, February 20, 2020 | NON-FINAL ACTION E-MAILED |
| Thursday, February 20, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, February 13, 2020 | ASSIGNED TO EXAMINER |
| Saturday, November 16, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 13, 2019 | NEW APPLICATION ENTERED |